Skip to main content
DNA Labs India

ROGDI Gene Kohlschutter Tonz syndrome NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

ROGDI Gene Kohlschutter Tonz syndrome NGS Genetic Test

Short Name: ROGDI Gene NGS Test

Also known as: Kohlschutter-Tonz Syndrome NGS Test, ROGDI Gene Sequencing Test, KTS Genetic Test, ROGDI Mutation Analysis

ROGDI Gene Kohlschutter Tonz syndrome NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports will be delivered within 3 to 4 weeks from the date of sample receipt at the laboratory. You will receive the conclusive clinical test report along with raw data files (FASTQ and VCF).. Free home collection in 300+ cities across India.

Genetic TestingAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this NGS genetic test is to detect pathogenic mutations in the ROGDI gene responsible for causing Kohlschutter-Tonz syndrome. Molecular confirmation helps clinicians establish an accurate diagnosis, distinguish KTS from other epileptic encephalopathies, provide prognosis, guide seizure management, and offer recurrence risk counselling to affected families.

Test Code
4164
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports will be delivered within 3 to 4 weeks from the date of sample receipt at the laboratory. You will receive the conclusive clinical test report along with raw data files (FASTQ and VCF).
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

No specific preparation is required. No fasting is needed. Please carry the test requisition form with complete clinical history. Inform the laboratory about any prior genetic testing or known familial mutations. A genetic counselling session is recommended before testing.

Method: Peripheral venipuncture / Finger prick / DNA extraction

Step 2

Laboratory Analysis

Approximately 2-3 ml of peripheral blood will be collected by a trained phlebotomist using a sterile needle and EDTA vacutainer. For FTA card collection, a single drop of blood is obtained by a finger prick and applied to the designated area. Extracted DNA can also be submitted directly.

Step 3

Report Delivery

The blood sample should be transported to the laboratory promptly. FTA cards should be air-dried at room temperature before sealing in the provided pouch. Results will be shared through the online portal, email, or WhatsApp within 3 to 4 weeks.

Timeline: Reports will be delivered within 3 to 4 weeks from the date of sample receipt at the laboratory. You will receive the conclusive clinical test report along with raw data files (FASTQ and VCF).

Patient Instructions

1
Before the Test:A genetic counselling session is recommended to draw a pedigree chart of family members affected with ROGDI Gene Kohlschutter Tonz syndrome. Provide complete clinical history and any prior genetic test results to the laboratory.
2
During the Test:A simple blood draw or FTA card sample collection is performed. This is a painless outpatient procedure that takes less than 5 minutes.
3
After the Test:No special precautions are required after sample collection. The laboratory will process the sample using NGS technology and reports will be available in 3 to 4 weeks.

About This Test

Who Should Get This Test

The purpose of this NGS genetic test is to detect pathogenic mutations in the ROGDI gene responsible for causing Kohlschutter-Tonz syndrome. Molecular confirmation helps clinicians establish an accurate diagnosis, distinguish KTS from other epileptic encephalopathies, provide prognosis, guide seizure management, and offer recurrence risk counselling to affected families.

How to Prepare

  • Blood sample must be collected in an EDTA (lavender top) vacutainer
  • For FTA card, a single drop of blood should be applied to each pre-printed circle and allowed to air dry
  • Label the sample with patient's full name, unique ID, and date of collection
  • Complete the requisition form including clinical history, pedigree, and signed informed consent
  • Do not freeze whole blood; store at 2-8°C if transport is delayed

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic counselling prior to testing is essential as Kohlschutter-Tonz syndrome follows autosomal recessive inheritance, giving parents a 25% recurrence risk with each pregnancy."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml whole blood OR 1 drop on FTA Card OR 1-5 µg extracted DNA
ContainerEDTA (Lavender top) vacutainer OR FTA Card OR sterile microcentrifuge tube
Collection MethodPeripheral venipuncture / Finger prick / DNA extraction

Sample Stability

Sample Rejection Criteria:
  • Hemolyzed blood samples
  • Clotted blood samples
  • Improperly labelled or unlabelled samples
  • Frozen whole blood samples
  • Samples received after more than 72 hours without cold chain
  • Incomplete requisition or missing consent form

Understanding Your Results

The clinical interpretation of ROGDI gene sequencing follows the ACMG/AMP guidelines and should be correlated with clinical presentation and family history.
📊

Pathogenic (Class 5)

Confirmed molecular diagnosis of Kohlschutter-Tonz syndrome; recurrence risk counselling strongly recommended

📊

Likely Pathogenic (Class 4)

High likelihood of disease causation; family segregation studies may be suggested to confirm

📊

Variant of Uncertain Significance (Class 3)

Insufficient evidence to determine pathogenicity; additional genetic testing of family members may be needed

📊

Benign (Class 1) / Likely Benign (Class 2)

No clinical significance; does not explain the patient's phenotype

⚠️ When to Consult a Doctor:

If a pathogenic or likely pathogenic variant is identified, please consult a clinical geneticist or neurologist for a comprehensive management plan. Genetic counselling is strongly recommended to understand the implications of results for the patient and family members.

Limitations

  • NGS may not reliably detect large structural rearrangements, deep intronic variants, or complex repeat expansions
  • Variants of uncertain significance (VUS) may require additional family testing
  • This test does not assess other genes associated with similar neurodevelopmental phenotypes
  • Copy number variants may require confirmation by MLPA or qPCR
  • Test results should always be interpreted in the context of clinical findings

Risks & Considerations

  • Minimal risk associated with routine blood collection
  • Mild bruising at the venipuncture site
  • Rare local infection or discomfort at the puncture site
  • No genetic risk from the test itself

Interfering Factors

  • Insufficient DNA quantity or quality
  • Contamination of blood sample during collection
  • Maternal cell contamination in prenatal samples
  • Uninformative or incomplete clinical history
  • Genetic variants of uncertain significance
  • Somatic mosaicism detected at low level

Compare With Similar Tests

TestROGDI Gene Kohlschutter Tonz syndrome NGS Genetic TestROGDI Gene NGS TestComprehensive Epilepsy NGS Panel
ComparisonROGDI Gene Kohlschutter Tonz syndrome NGS Genetic Test

Frequently Asked Questions

What is Kohlschutter-Tonz syndrome?
Kohlschutter-Tonz syndrome is a rare autosomal recessive neurological disorder characterised by the triad of early-onset seizures, severe intellectual disability, and dental enamel defects (amelogenesis imperfecta). It is caused by mutations in the ROGDI gene.
How is Kohlschutter-Tonz syndrome inherited?
Kohlschutter-Tonz syndrome follows an autosomal recessive inheritance pattern. Affected individuals carry two mutated copies of the ROGDI gene. Parents of an affected child are typically asymptomatic carriers, with a 25% recurrence risk in each pregnancy.
What does the ROGDI gene NGS genetic test detect?
The test uses next-generation sequencing to identify mutations in the entire coding region and exon-intron boundaries of the ROGDI gene. It can detect single-nucleotide variants, small insertions and deletions, and, with appropriate bioinformatic analysis, some copy number changes.
What sample type is required for this test?
The sample can be peripheral blood collected in an EDTA vacutainer, extracted DNA from a patient, or one drop of blood applied to an FTA card. Home sample collection is available across India for online bookings.
Is fasting required before giving the blood sample?
No, fasting is not required for this genetic test. You can eat and drink normally before sample collection.
How long will the test take to produce results?
The turnaround time for the ROGDI gene NGS genetic test is 3 to 4 weeks from the time the sample is received at the laboratory. Reports are delivered via online portal, email, and WhatsApp.
Does DNA Labs India provide raw data files with the report?
Yes. DNA Labs India is transparent and will share raw data files (FASTQ and VCF) along with the conclusive clinical test report for the ROGDI Gene Kohlschutter Tonz syndrome NGS Genetic Test.
What is the cost of the ROGDI gene NGS test?
The test is available at a special discounted price of INR 20,000 across India. Free home sample collection is also offered for online bookings, making it convenient for patients across all major cities.
Who should consider taking this test?
Individuals with clinical features suggestive of Kohlschutter-Tonz syndrome, including early-onset epilepsy, intellectual disability, and dental enamel abnormalities, as well as family members of affected individuals and at-risk couples, should consider this test.
Are there any risks associated with this genetic test?
The physical risks are minimal and limited to routine blood collection, which may cause mild discomfort, bruising, or very rarely infection at the puncture site. No additional procedural risks are involved.
Will this test detect all causes of early-onset epilepsy?
No. The ROGDI gene test specifically targets mutations in the ROGDI gene associated with Kohlschutter-Tonz syndrome. Other genetic causes of epilepsy are not assessed by this test. A comprehensive epilepsy panel or whole exome sequencing may be recommended for broader evaluation.
What are the benefits of a molecular genetic diagnosis for KTS?
A confirmed genetic diagnosis provides certainty about the underlying cause, facilitates accurate recurrence risk counselling, guides medical management of seizures, assists in prognosis, and supports informed family planning decisions including prenatal and preimplantation genetic testing.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.